Pirfetab 267 Tablet

By Pirfetab

Rx

10 Tablet in a Strip

Composition icon

Composition

Pirfenidone(267mg)

Manufacturer - Zydus Cadila icon

Manufacturer - Zydus Cadila

Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after icon

Expires on or after

December, 2025

About Pirfetab 267 Tablet

Pirfetab 267 Tablet, also known as Pirfetab 267 Tablet 10's, is a prescribed medication used to treat idiopathic pulmonary fibrosis (IPF) in adults. This condition involves a progressive decline in lung function due to swelling and scarring of lung tissues over time, making breathing difficult. Pirfetab 267 Tablet 10's contains Pirfenidone, an anti-fibrotic agent that works by reducing scarring and swelling in the lungs. By decreasing the release and activity of certain growth factors in the body, Pirfetab 267 Tablet 10's helps improve breathing and slows down the progression of IPF.

When taking Pirfetab 267 Tablet 10's, it is recommended to consume it with food at the same time each day to maximize its benefits. The dosage and frequency of intake will be determined by your doctor based on your specific condition and symptoms. It is essential to follow your doctor's instructions and continue taking the medication for the prescribed duration.

While Pirfetab 267 Tablet 10's can be effective in treating IPF, it may also cause some common side effects such as nausea, tiredness, diarrhea, indigestion, headache, and photosensitivity. These side effects usually do not require medical intervention and tend to resolve gradually. However, if you experience persistent side effects or concerns, it is advisable to consult your doctor for guidance.

Before starting Pirfetab 267 Tablet 10's, inform your doctor about any liver or kidney diseases you may have, as well as any other medications you are taking. Some drugs may interact with Pirfetab 267 Tablet 10's, affecting its effectiveness or how it works in your body. Additionally, if you are pregnant or breastfeeding, seek advice from your healthcare provider before using this medication.

To enhance the safety and effectiveness of Pirfetab 267 Tablet 10's, it is recommended to avoid activities that require alertness, such as driving, especially if you experience dizziness. Furthermore, alcohol consumption should be avoided while taking this medication to prevent increased dizziness. Pirfetab 267 Tablet 10's is not intended for use in individuals under 18 years of age, and caution should be exercised in elderly patients aged 65 years and above. It is important to keep your doctor informed about your health condition and any changes that may occur during treatment to minimize the risk of potential side effects.


Benefits

Pirfetab 267 Tablet, specifically formulated to treat idiopathic pulmonary fibrosis (IPF) in adults, offers a range of benefits for individuals struggling with this lung disease. People with IPF often face difficulties due to their lung tissues becoming thick and stiff, leading to the formation of scar tissue in the lungs. This scarring process, known as fibrosis, occurs due to a cycle of lung damage and healing, resulting in irreversible changes. Common initial symptoms of IPF include shortness of breath and a dry cough.

Thankfully, Pirfetab 267 Tablet plays a crucial role in combating the effects of IPF. By reducing scarring and fibrosis in the lungs, this medication significantly improves breathing capacity, making it easier for individuals to breathe. In addition, Pirfetab 267 Tablet has been shown to slow the rate of lung function decline by an impressive 50%, providing much-needed relief and support for those dealing with the challenges of IPF.

The effectiveness of Pirfetab 267 Tablet lies in its ability to decrease the release and activity of naturally occurring growth factors in the body. By reducing scarring and swelling in the lungs, this anti-fibrotic medicine helps individuals breathe more comfortably and efficiently. Moreover, Pirfetab 267 Tablet not only alleviates symptoms but also aids in slowing down the progression of idiopathic pulmonary fibrosis, offering hope and improved quality of life for patients.

It is essential to note that while Pirfetab 267 Tablet offers significant benefits in managing IPF, individuals may experience some bothersome side effects. Therefore, it is crucial to consult with a healthcare professional and discuss any concerns or doubts regarding the medication. Overall, Pirfetab 267 Tablet stands out as a valuable treatment option for individuals grappling with idiopathic pulmonary fibrosis, providing relief, slowing disease progression, and enhancing overall respiratory function.


How to use the Pirfetab 267 Tablet

To use Pirfetab 267 Tablet correctly, it is essential to follow your doctor's instructions regarding the dose and duration of the medication. Take Pirfetab 267 Tablet with food for best results. Swallow the tablet whole with a glass of water, and do not chew, crush, or break it before consumption. Make sure to take Pirfetab 267 Tablet as directed by your healthcare provider to ensure its effectiveness and safety. If you have any concerns or questions about using Pirfetab 267 Tablet, consult your doctor for guidance.


Uses of Pirfetab 267 Tablet

Pirfetab 267 Tablet is primarily used in the treatment of Idiopathic pulmonary fibrosis, a condition that causes scarring in the lungs. By targeting this specific condition, Pirfetab 267 Tablet helps to alleviate respiratory symptoms and improve overall lung function. This medication plays a crucial role in managing the progression of Idiopathic pulmonary fibrosis, offering relief to individuals affected by this challenging lung disorder.


What conditions Pirfetab 267 Tablet treats?

Pirfetab 267 Tablet is used to manage Idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes inflammation and scarring of lung tissues. IPF leads to breathing difficulties due to thickening and stiffening of scar tissue in the lungs. Symptoms include shortness of breath, dry cough, weight loss, and changes in fingers and toes. Pirfetab 267 Tablet helps in improving lung function and alleviating symptoms associated with IPF.


Should you consult a doctor?

If you experience persistent side effects such as insomnia, headache, dizziness, or gastrointestinal issues like nausea, diarrhea, and indigestion while taking Pirfetab 267 Tablet, you should consult your doctor. Additionally, if you notice any unusual symptoms like sudden weight loss, or if you have concerns about changes in your overall health, it is advisable to seek medical advice promptly. Inform your healthcare provider if you have liver or kidney disease before starting this medication, as well as any other treatments you are currently taking, to ensure its effectiveness. If you are pregnant or breastfeeding, discuss this with your doctor to determine the best course of action. It is important to follow your doctor's recommendations and report any persistent or concerning symptoms to ensure your well-being during the course of treatment with Pirfetab 267 Tablet.


Side effects of Pirfetab 267 Tablet

When taking Pirfetab 267 Tablet, some individuals may experience certain side effects. These effects usually do not need medical attention and tend to fade as the body gets used to the medicine. However, consulting a doctor is important if these side effects persist or cause concern. Common side effects of Pirfetab 267 Tablet may include insomnia, which can lead to difficulty in sleeping, as well as headaches, dizziness, and tiredness. Sinus inflammation and upper respiratory tract infection are also possible side effects. Some individuals may experience weight loss, nausea, indigestion, or diarrhea while taking this medication. Additionally, photosensitivity, where the skin becomes more sensitive to sunlight, can occur. Loss of appetite is another potential side effect, along with symptoms such as tiredness, diarrhea, indigestion, and a stomach upset. These side effects should be monitored, and any concerns should be discussed with a healthcare provider.


Safety advice

scroll

liver

When using Pirfetab 267 Tablet, it is important to exercise caution if you have liver disease. In such cases, a dose adjustment of the tablet may be necessary. It is highly advised to consult with your doctor before starting or continuing the use of Pirfetab 267 Tablet, especially if you have any liver issues. It is not recommended to use this tablet in patients with severe liver disease. Always seek medical advice and guidance to ensure the safe use of Pirfetab 267 Tablet in relation to your liver health.

scroll

kidney

Pirfetab 267 Tablet requires caution in patients with kidney disease. Dosage adjustment may be necessary. Avoid use in severe kidney disease and dialysis patients. Consult your doctor for guidance.

scroll

alcohol

Consult your doctor when consuming alcohol with Pirfetab 267 Tablet.

scroll

driving

When taking Pirfetab 267 Tablet, be cautious while driving as it may reduce alertness, cause dizziness, affect vision, and lead to drowsiness. Avoid driving if experiencing these side effects to ensure safety on the road.

scroll

pregnancy

Pirfetab 267 Tablet is not recommended for use during pregnancy as it may pose risks to the developing baby based on animal studies. Consult your doctor to discuss any potential risks and benefits before taking this medication during pregnancy.

scroll

breastfeeding

It is better to consult your doctor before using Pirfetab 267 Tablet during breastfeeding.


Consumption warning before consuming Pirfetab 267 Tablet

Before taking Pirfact 267 mg Tablet 10's, be cautious if you are allergic to any of its components, have severe liver or kidney issues, or are taking fluvoxamine. Inform your doctor if you are on photosensitive medications, have kidney or liver problems, smoke, or are pregnant or breastfeeding. This medicine may cause tiredness and dizziness, impacting your ability to drive, so be careful. Avoid alcohol while on Pirfact 267 mg Tablet 10's to prevent increased dizziness. It is not suitable for children under 18 due to uncertain safety and effectiveness.


Disease interactions

When taking Pirfetab 267 Tablet, it is important to inform your doctor if you have severe liver problems or end-stage kidney disease that requires dialysis. These conditions can impact how your body processes the medication and may require special monitoring or adjustments in dosage to ensure safety and effectiveness. By communicating openly with your healthcare provider about your medical history and any ongoing health issues, you can help to minimize the risk of potential interactions between the drug and your existing conditions.


Additional Information

Habit FormingNo
Chemical ClassPyridones Derivative
Therapeutic Class-
Action ClassIdiopathic pulmonary fibrosis (IPF)

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

332.75

Inclusive of all taxes

Content verified by

chevron-right

Dr. Mansi Chaudhari

MBBS - General Medicine

Last update on 11-Feb-2025